Detailed view for this entity.
“Novo Nordisk remains the number one overall GLP market leader with a 62% volume market share in international operations in the US.”
“Novo is doing much better in international operations compared to the United States. Market share losses and realized lower prices are part of the reason why it's underperforming in the unit.”
“But Novo Nordisk underperformed last year and it's underperforming to begin 2025 2026. And one of the reasons is the pressure from the US administration.”